What are Clinical Trials and why do we need them?
Clinical trials are carefully designed research studies conducted in humans to evaluate the safety, efficacy, and overall benefit of medical interventions such as drugs, biologics, or devices. They progress through phases 1 to 4, each with distinct goals, methods, and regulatory requirements. Below is a full explanation of each phase: 🔬 Preclinical Studies (Before Phase […]
Omada Health Shares Soar After IPO as GLP-1 Drugs Fuel Interest
Post Content
Ozempic’s hidden dangers: Muscle loss, mental health warnings and the rebound effect
(NaturalNews) Ozempic/Wegovy users risk losing muscle, bone mass and mental health as severe side effects. GLP-1 drugs linked to 62,000 adverse events and 16…
It’s OK not to be fat
“Pharmacist Holding a Box of Ozempic” by chemist4u, CC BY 2.0 “O God, give us the serenity to accept what cannot be changed, the courage to change what can be changed, and the wisdom to know the one from the other.” — Winnifred Wygal “Put the fork down!” — Denis Leary I was going to […]
GLP-1 Drugs Linked to Age-Related Macular Degeneration, Study Finds
GLP-1 drugs like Ozempic could lead to a higher risk of wet age-related macular degeneration in people with type 2 diabetes. Westend61/Getty Images GLP-1 drugs are associated with a higher risk of “wet” age-related macular degeneration in people with type 2 diabetes, according to a new study. Researchers found that the risk substantially increased the […]
EMA warns Ozempic linked to ‘very rare’ side effect
The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in which the optic nerve is damaged by a sudden loss of blood supply. After reviewing several large epidemiological studies, clinical trial and in-market data, EMA’s Pharmacovigilance Risk Assessment Committee has […]
GLP-1 drugs are rewriting America’s food preferences, says IFF: ‘GLP-1s alter taste perception’
Eighty-five percent of US GLP-1 drug consumers report major changes in their food and beverage preferences after starting the medications, says a new report from ingredients giant IFF. And it’s not just about cutting down on junk food. “GLP-1s alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel, […]
GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes
FRIDAY, June 6, 2025 — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular degeneration (nAMD) development, according to a…
EMA considers serious eye condition a ‘very rare’ side effect of semaglutide
The European Medicines Agency said Friday that the product information for Novo Nordisk’s Ozempic and Wegovy should be updated to list a serious eye condition as a “very rare” side effect. A
GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns
(MedPage Today) — A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. Following a review of all available data, the…